We have observed that immunocompromised patients with HIV or T2DM have decreased levels of GSH, have increased levels of ROS, increased levels of proinflammatory and immunosuppressive cytokines such as TGF-β, and have an impaired ability to clear an M. tb infection in vitro. The gene discussed is TGFB1; the disease is type 2 diabetes mellitus.